NextCure, Inc. (NXTC) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $25.98M | -6.3% |
| 2024 | $27.73M | +111.9% |
| 2023 | $13.08M | -50.9% |
| 2022 | $26.63M | +115.9% |
| 2021 | $12.34M | -62.4% |
| 2020 | $32.77M | -3.9% |
| 2019 | $34.09M | -74.8% |
| 2018 | $135.17M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $25.98M | -6.3% |
| 2024 | $27.73M | +111.9% |
| 2023 | $13.08M | -50.9% |
| 2022 | $26.63M | +115.9% |
| 2021 | $12.34M | -62.4% |
| 2020 | $32.77M | -3.9% |
| 2019 | $34.09M | -74.8% |
| 2018 | $135.17M | — |